MUTANTE CAS9-PROTEINE

European patent · EP3071694 · In force

Register entry

Publication number
EP3071694
Application number
EP14864613
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 19, 2014
Published
Sep 28, 2016
Granted
Jan 8, 2020
Protection ends at the latest
Nov 18, 2034
Next annual fee due
Nov 30, 2026
IPC classes
C12N 9/22 (2006.01)
C07H 21/04 (2006.01)
Priority
US 201361906374 P 19.11.2013
PCT application
PCT/US2014/066375 19.11.2014
PCT publication
WO2015/077318 28.05.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  3. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  4. May 8, 2023

    Address changed

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 08.05.2023

  5. Dec 6, 2022

    Change

    Published in Swissreg on 06.12.2022

  6. Feb 28, 2020

    Agent entered

    Representative
    Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel

    Published in Swissreg on 28.02.2020

  7. Jan 8, 2020

    Granted

    Published in Swissreg on 08.01.2020

Parties

Holder

President and Fellows of Harvard College

17 Quincy Street, Cambridge, MA 02138, US

Agent

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventor

CHAVEZ, Alejandro

Brookline, Massachusetts 02446, US

CHURCH, George M.

Brookline, Massachusetts 02446, US

POELWIJK, Franck

Dallas, Texas 75231, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.